Supplemental Breast MR Imaging Screening of Women with Average Risk of Breast Cancer.
暂无分享,去创建一个
Simone Schrading | Hans H Schild | C. Kuhl | C. Leutner | H. Schild | H. Bieling | S. Schrading | Kevin Strobel | Heribert Bieling | Claudia Leutner | Christiane K Kuhl | Kevin Strobel
[1] Eun-Kyung Kim,et al. Triple-negative invasive breast cancer on dynamic contrast-enhanced and diffusion-weighted MR imaging: comparison with other breast cancer subtypes , 2012, European Radiology.
[2] G. Farshid,et al. Risk profile of breast cancer following atypical hyperplasia detected through organized screening. , 2015, Breast.
[3] Mammographic density and survival in interval breast cancers , 2013, Breast Cancer Research.
[4] A R Padhani,et al. Screening with magnetic resonance imaging and mammography of a UK population at high familial risk of breast cancer: a prospective multicentre cohort study (MARIBS) , 2005, The Lancet.
[5] M. Yaffe,et al. Long-term results of screening with magnetic resonance imaging in women with BRCA mutations , 2012, British Journal of Cancer.
[6] T. Endo,et al. Sensitivity and specificity of mammography and adjunctive ultrasonography to screen for breast cancer in the Japan Strategic Anti-cancer Randomized Trial (J-START): a randomised controlled trial , 2016, The Lancet.
[7] P. Hall,et al. Breast cancer genetic risk profile is differentially associated with interval and screen-detected breast cancers. , 2015, Annals of oncology : official journal of the European Society for Medical Oncology.
[8] Daniel B Kopans,et al. The pattern of breast cancer screening utilization and its consequences , 2002, Cancer.
[9] Etta D Pisano,et al. Detection of breast cancer with addition of annual screening ultrasound or a single screening MRI to mammography in women with elevated breast cancer risk. , 2012, JAMA.
[10] A Russell Localio,et al. Multimodality screening of high-risk women: a prospective cohort study. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[11] Shu Ichihara,et al. Breast cancer prognostic classification in the molecular era: the role of histological grade , 2010, Breast Cancer Research.
[12] Rebecca A Hubbard,et al. Outcomes of screening mammography by frequency, breast density, and postmenopausal hormone therapy. , 2013, JAMA internal medicine.
[13] H. D. de Koning,et al. Overdiagnosis by mammographic screening for breast cancer studied in birth cohorts in The Netherlands , 2015, International journal of cancer.
[14] Maximilian Reiser,et al. Prospective multicenter cohort study to refine management recommendations for women at elevated familial risk of breast cancer: the EVA trial. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[15] Janice S. Sung,et al. Screening breast MR imaging in women with a history of lobular carcinoma in situ. , 2011, Radiology.
[16] Janice S. Sung,et al. Screening breast MR imaging in women with a history of chest irradiation. , 2011, Radiology.
[17] Laura Cortesi,et al. Multicenter comparative multimodality surveillance of women at genetic-familial high risk for breast cancer (HIBCRIT study): interim results. , 2007, Radiology.
[18] C R Key,et al. Biologic characteristics of interval and screen-detected breast cancers. , 2000, Journal of the National Cancer Institute.
[19] E. Halpern,et al. A simple model of breast carcinoma growth may provide explanations for observations of apparently complex phenomena , 2003, Cancer.
[20] Derek C. Radisky,et al. Understanding the Premalignant Potential of Atypical Hyperplasia through Its Natural History: A Longitudinal Cohort Study , 2014, Cancer Prevention Research.
[21] Brian L Sprague,et al. Screening ultrasound as an adjunct to mammography in women with mammographically dense breasts. , 2015, American journal of obstetrics and gynecology.
[22] M Moskowitz,et al. Occult breast cancer: prevalence and radiographic detectability. , 1987, Radiology.
[23] H. D. de Koning,et al. Efficacy of MRI and mammography for breast-cancer screening in women with a familial or genetic predisposition. , 2004, The New England journal of medicine.
[24] N. Hylton,et al. Magnetic resonance imaging as a predictor of pathologic response in patients treated with neoadjuvant systemic treatment for operable breast cancer , 2013, Cancer.
[25] M. Gail,et al. Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. , 1989, Journal of the National Cancer Institute.
[26] T. Helbich,et al. Triple-modality screening trial for familial breast cancer underlines the importance of magnetic resonance imaging and questions the role of mammography and ultrasound regardless of patient mutation status, age, and breast density. , 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[27] Phoebe E. Freer,et al. Breast-density legislation--practical considerations. , 2015, The New England journal of medicine.
[28] D. Miglioretti,et al. Individual and Combined Effects of Age, Breast Density, and Hormone Replacement Therapy Use on the Accuracy of Screening Mammography , 2003, Annals of Internal Medicine.
[29] H. D. de Koning,et al. Survival benefit in women with BRCA1 mutation or familial risk in the MRI screening study (MRISC) , 2015, International journal of cancer.
[30] S. Duffy,et al. Impact of Screening on Breast Cancer Mortality: The UK Program 20 Years On , 2015, Cancer Epidemiology, Biomarkers & Prevention.
[31] M. Leach,et al. MRI breast screening in high-risk women: cancer detection and survival analysis , 2014, Breast Cancer Research and Treatment.
[32] C. Gatsonis,et al. MRI evaluation of the contralateral breast in women with recently diagnosed breast cancer. , 2007, The New England journal of medicine.
[33] John Kornak,et al. MRI Enhancement in Stromal Tissue Surrounding Breast Tumors: Association with Recurrence Free Survival following Neoadjuvant Chemotherapy , 2013, PloS one.
[34] John Kornak,et al. Optimized breast MRI functional tumor volume as a biomarker of recurrence‐free survival following neoadjuvant chemotherapy , 2014, Journal of magnetic resonance imaging : JMRI.
[35] A. Ng,et al. Breast cancer detection among young survivors of pediatric Hodgkin lymphoma with screening magnetic resonance imaging , 2014, Cancer.
[36] Eugenio Paci,et al. Overdiagnosis in Mammographic Screening for Breast Cancer in Europe: A Literature Review , 2012, Journal of medical screening.
[37] Markus Hahn,et al. Early detection of breast cancer: benefits and risks of supplemental breast ultrasound in asymptomatic women with mammographically dense breast tissue. A systematic review , 2009, BMC Cancer.
[38] Ralf-Dieter Hilgers,et al. Abbreviated breast magnetic resonance imaging (MRI): first postcontrast subtracted images and maximum-intensity projection-a novel approach to breast cancer screening with MRI. , 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[39] Jean B. Cormack,et al. Combined screening with ultrasound and mammography vs mammography alone in women at elevated risk of breast cancer. , 2008, JAMA.
[40] Emily F Conant,et al. Breast cancer screening using tomosynthesis in combination with digital mammography. , 2014, JAMA.